NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 237 filers reported holding NEKTAR THERAPEUTICS in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,125,000 | +15.4% | 106,238 | -1.9% | 0.68% | +5.9% |
| Q4 2020 | $1,842,000 | -6.8% | 108,342 | -9.1% | 0.64% | -30.4% |
| Q3 2020 | $1,977,000 | -29.7% | 119,198 | -1.8% | 0.92% | -34.5% |
| Q2 2020 | $2,813,000 | +26.8% | 121,439 | -2.3% | 1.41% | +3.7% |
| Q1 2020 | $2,219,000 | -12.8% | 124,292 | +5.4% | 1.36% | +21.7% |
| Q4 2019 | $2,545,000 | +28.7% | 117,910 | +8.6% | 1.11% | +12.3% |
| Q3 2019 | $1,977,000 | -42.3% | 108,540 | +12.8% | 0.99% | -42.2% |
| Q2 2019 | $3,424,000 | – | 96,226 | – | 1.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
| Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
| Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
| Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
| BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
| First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
| Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
| SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
| QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
| Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |